$30.00
ARA-290 (also known as cibinetide) is an experimental synthetic peptide studied for its anti-inflammatory, tissue-protective, and nerve-support effects. It is not FDA-approved for general use.
ARA-290 is a small peptide derived from a portion of the hormone erythropoietin (EPO), but it is engineered to avoid the red blood cell–stimulating effects of EPO.
Instead, it targets a specific receptor known as the innate repair receptor (IRR), which is involved in:
ARA-290 is studied for reducing chronic inflammation without suppressing the immune system.
One of its most researched areas is neuropathic pain, including:
May help protect and repair tissues after injury or stress by activating healing pathways.
Associated with improved microvascular function (small blood vessels), which may support tissue oxygenation.
Studied in conditions like:
ARA-290 may:
ARA-290 is a tissue-protective and anti-inflammatory peptide primarily studied for nerve pain, inflammation reduction, and cellular repair, but it remains investigational.
